Cargando…
Unveiling Disrupted Lipid Metabolism in Benign Prostate Hyperplasia, Prostate Cancer, and Metastatic Patients: Insights from a Colombian Nested Case–Control Study
SIMPLE SUMMARY: Prostate cancer represents a substantial global health issue, and its intricacies continue to pose challenges for complete comprehension. In this study, an untargeted metabolomic and lipidomic approach was employed to analyze plasma samples obtained from patients diagnosed with benig...
Autores principales: | Pardo-Rodriguez, Daniel, Santamaría-Torres, Mary, Salinas, Angela, Jiménez-Charris, Eliécer, Mosquera, Mildrey, Cala, Mónica P., García-Perdomo, Herney Andrés |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670336/ https://www.ncbi.nlm.nih.gov/pubmed/38001725 http://dx.doi.org/10.3390/cancers15225465 |
Ejemplares similares
-
Benign Prostatic Hyperplasia
Publicado: (2015) -
Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015) -
Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997) -
Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012) -
Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)